Design and validation of revised medication assessment tool for community-acquired Pneumonia: rMAT-CAP
Sahar Elnajjar, Sabariah Noor Harun, Semira Beshir, Ali Qureshi, Dujana Al Hamed, Hebah Al Jaghoub, Hamzeh Al Subbah, Danish Khowaja · 2026
Read Design and validation of revised medication assessment tool for community-acquired Pneumonia: rMAT-CAP by Sahar Elnajjar, Sabariah Noor Harun, Semira Beshir, Ali Qureshi, Dujana Al Hamed, Hebah Al Jaghoub, Hamzeh Al Subbah, Danish Khowaja (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13411974.txt.
Description
Sahar Elnajjar and colleagues revised and validated a pneumonia medicine checklist for hospitals in the United Arab Emirates in 2026. The Norwegian original no longer matched current treatment guidelines or local drug resistance, so the team rebuilt its criteria, tested them with ten experts, and checked them against 30 real cases.
The revised tool holds 13 criteria covering drug choice, lab testing, dosing, switching from drip to pills, and course length, with near-perfect expert agreement on drug choice. Stewardship teams gain a local, tested checklist for judging whether pneumonia antibiotics are truly appropriate.
Catalog record
| CREATOR | Sahar Elnajjar, Sabariah Noor Harun, Semira Beshir, Ali Qureshi, Dujana Al Hamed, Hebah Al Jaghoub, Hamzeh Al Subbah, Danish Khowaja |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |